Results 121 to 130 of about 2,572,587 (193)

Risk of Diabetes-Specific Eating Disorders in Children with Type 1 Diabetes Mellitus Using Continuous Subcutaneous Insulin Infusion: A CGM-Based Cross-Sectional Study. [PDF]

Medicina (Kaunas)
Köprülü Ö, Tan H, Erbaş İM, Şimşek FY, Uyar N, Karataş MÇ, Nalbantoğlu Ö, Korkmaz HA, Özkan B.   +8 more
europepmc   +1 more source

Continuous Subcutaneous Insulin Infusion Versus Multiple Daily Injections for Glycemic Management in Pregnant Women With Type 1 Diabetes: A Systematic Review and Meta-Analysis. [PDF]

AACE Endocrinol Diabetes
Alonso Ramírez AC, Salazar Ore JV, Murga O, Salvatierra Moreno SC, Devita HL, Nieto M, John J, Aly L, Briceno Silva GD, Zachariah Saji S, Arruarana VS, Correa Marquez R, Calderón Martinez E.   +12 more
europepmc   +1 more source

Hypoglycemia and glycemic variability of people with type 1 diabetes with lower and higher physical activity loads in free-living conditions using continuous subcutaneous insulin infusion with predictive low-glucose suspend system. [PDF]

BMJ Open Diabetes Res Care, 2023
Montt-Blanchard D, Sánchez R, Dubois-Camacho K, Leppe J, Onetto MT.   +4 more
europepmc   +1 more source

Insulin Requirement Profiles of Short-Term Continuous Subcutaneous Insulin Infusion Therapy in Patients With Type 2 Diabetic Nephropathy. [PDF]

Int J Endocrinol
Feng Q, Li B, Lin J, Zou L, Xu W, Zeng L, Li P, Lin S.   +7 more
europepmc   +1 more source

Comparing the effectiveness of continuous subcutaneous insulin infusion with multiple daily insulin injection for patients with type 1 diabetes mellitus evaluated by retrospective continuous glucose monitoring: A real-world data analysis. [PDF]

Front Public Health, 2022
Keyu G, Jiaqi L, Liyin Z, Jianan Y, Li F, Zhiyi D, Qin Z, Xia L, Lin Y, Zhiguang Z.   +9 more
europepmc   +1 more source

Existing Knowledge Gaps in Risk Factors and Consequences of Lipohypertrophy in People Using Continuous Subcutaneous Insulin Infusion Therapy: A Systematic Review and Meta-analysis. [PDF]

J Diabetes Sci Technol
Mader JK, Fornengo R, Hassoun A, Heinemann L, Kulzer B, Monica M, Nguyen T, Sieber J, Renard E, Reznik Y, Ryś P, Stożek-Tutro A, Wilmot EG.   +12 more
europepmc   +1 more source

Continuous subcutaneous insulin infusion therapy is associated with reduced retinopathy progression compared with multiple daily injections of insulin. [PDF]

Diabetologia, 2021
Reid LJ, Gibb FW, Colhoun H, Wild SH, Strachan MWJ, Madill K, Dhillon B, Forbes S.   +7 more
europepmc   +1 more source

Long-term health economic evaluation of automated insulin delivery system compared with continuous subcutaneous insulin infusion pumps and CGM in a real-world setting in Finnish paediatric and adult individuals with type 1 diabetes. [PDF]

Diabetes Obes Metab
Vallivaara HL, Leppänen HA, Mustonen J, Saari A, Martikainen J, Rintamäki RM.   +5 more
europepmc   +1 more source

Continuous subcutaneous insulin infusion is associated with a better glycemic control than multiple daily insulin injections without difference in diabetic ketoacidosis and hypoglycemia admissions among Emiratis with Type 1 diabetes. [PDF]

PLoS One, 2022
Almazrouei R, Sharma C, Afandi B, Aldahmani KM, Aburawi EH, Beshyah SA, ElGhazali G, Al Yafei Z, Al-Rifai RH, Alkaabi J.   +9 more
europepmc   +1 more source

Audit on continuous subcutaneous insulin infusion [PDF]

Endocrine Abstracts, 2013
Nyi Htwe, Robert Skelly
openaire   +1 more source